This product is a combination treatment for type-2 diabetes, designed to help manage blood sugar levels in patients who do not achieve adequate control with other medications alone.
It includes two active ingredients that work together to improve insulin sensitivity, regulate glucose production, and increase insulin production.


Benefits:
Helps improve blood glucose control in patients with type-2 diabetes.
It supports better insulin production, improves insulin sensitivity, and reduces glucose production by the liver.
It reduces the risk of diabetic complications by controlling blood glucose levels.
The combination has a lower risk of causing low blood sugar (hypoglycemia) compared to sulfonylureas.

Precautions:
Liver function tests are required before and during treatment.
It is not recommended in patients with severe kidney disease.
Dose adjustments are needed for patients with kidney issues.
Blood sugar levels should be monitored regularly to avoid hypoglycemia, especially when used with insulin.
It is not suitable for patients allergic to any of the active ingredients.
The medication should be part of a complete treatment program that may also include diet, exercise, and weight control.

Main Ingredients & Their Benefits:
Vildagliptin: A DPP-4 inhibitor that enhances the body’s natural incretin hormones, leading to increased insulin production when needed and reduced glucose output from the liver.
Metformin: Reduces glucose production in the liver and improves the body's sensitivity to insulin, helping to control blood sugar levels more effectively.

Side Effects:
Dizziness (common).
Symptoms of low blood sugar such as nausea, irregular heart rate, hunger, and sweating (especially when used with insulin or sulfonylureas).
Gastrointestinal discomfort, such as nausea or diarrhea.
Possible liver function abnormalities.
Fatigue or muscle aches.